Faeth Therapeutics, Inc. (FTH) — Institutional Holders, Q1 2025
21 institutional investment managers reported a FTH position on SEC Form 13F-HR for the quarter ended March 31, 2025, with a combined reported value of $760.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
FTH in Q1 2025: what funds did
Funds that filed a 13F for both Q4 2024 and Q1 2025, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- UBS Group AGNew · +42,541 sh+$16.8K
- RENAISSANCE TECHNOLOGIESAdded · +20,500 sh+$8.1K
- BARCLAYS PLCNew · +2,558 sh+$1.0K
- GEODE CAPITAL MANAGEMENTAdded · +1,822 sh+$718.00
- CITIGROUPNew · +124 sh+$49.00
Biggest sellers
- Ikarian CapitalTrimmed · -200,000 sh-$78.8K
- BOOTHBAY FUND MANAGEMENTTrimmed · -64,140 sh-$25.3K
- XTX Topco LtdSold out · -62,903 sh-$24.8K
- CITADEL ADVISORSSold out · -57,717 sh-$22.7K
- BRIDGEWAY CAPITAL MANAGEMENTSold out · -47,900 sh-$18.9K
FTH 13F holders ranked 1–21 of 21
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q4 2024 |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP#1 · 585,576 sh | 585,576 | $230.7K | — | -1.5% |
| 2 | Ikarian Capital#2 · 449,963 sh | 449,963 | $177.3K | — | -30.8% |
| 3 | Catalio Capital Management#3 · 294,374 sh | 294,374 | $116.0K | — | 0.0% |
| 4 | RENAISSANCE TECHNOLOGIES#4 · 177,300 sh | 177,300 | $69.9K | — | +13.1% |
| 5 | GEODE CAPITAL MANAGEMENT#5 · 150,709 sh | 150,709 | $59.4K | — | +1.2% |
| 6 | BOOTHBAY FUND MANAGEMENT#6 · 108,658 sh | 108,658 | $42.8K | — | -37.1% |
| 7 | UBS Group AG#7 · 42,541 sh | 42,541 | $16.8K | — | New |
| 8 | NORTHERN#8 · 25,983 sh | 25,983 | $10.2K | — | 0.0% |
| 9 | STATE STREET#9 · 25,774 sh | 25,774 | $10.2K | — | 0.0% |
| 10 | Cresset Asset Management#10 · 19,671 sh | 19,671 | $7.8K | — | 0.0% |
| 11 | NWF Advisory Services#11 · 16,514 sh | 16,514 | $6.5K | — | 0.0% |
| 12 | RAYMOND JAMES FINANCIAL#12 · 14,000 sh | 14,000 | $5.5K | — | -50.0% |
| 13 | MORGAN STANLEY#13 · 9,219 sh | 9,219 | $3.6K | — | 0.0% |
| 14 | Tower Research Capital (TRC)#14 · 5,404 sh | 5,404 | $2.1K | — | -0.8% |
| 15 | BARCLAYS PLC#15 · 2,558 sh | 2,558 | $1.0K | — | New |
| 16 | JPMORGAN CHASE#16 · 702 sh | 702 | $276.00 | — | -0.4% |
| 17 | BNP PARIBAS FINANCIAL MARKETS#17 · 160 sh | 160 | $63.00 | — | 0.0% |
| 18 | BANK OF AMERICA#18 · 142 sh | 142 | $56.00 | — | +4.4% |
| 19 | CITIGROUP#19 · 124 sh | 124 | $49.00 | — | New |
| 20 | SBI Securities , Ltd.#20 · 92 sh | 92 | $36.00 | — | +29.6% |
| 21 | PROEQUITIES#21 · 0 sh | 0 | $0.00 | — | New |
Funds that sold out of FTH in Q1 2025 (6)
Held FTH at the end of Q4 2024 and filed a Q1 2025 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q4 2024 |
|---|---|---|
| XTX Topco Ltd62,903 sh | 62,903 | $30.8K |
| CITADEL ADVISORS57,717 sh | 57,717 | $28.3K |
| BRIDGEWAY CAPITAL MANAGEMENT47,900 sh | 47,900 | $23.5K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP38,051 sh | 38,051 | $18.6K |
| Deuterium Capital Management11,000 sh | 11,000 | $5.4K |
| HRT FINANCIAL11,600 sh | 11,600 | $5.0K |
Source: Form 13F-HR filings on SEC EDGAR, Q1 2025. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q4 2024 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.